Seres Therapeutics Inc (MCRB) — Cash Flow Reinvestment Rate
Seres Therapeutics Inc (MCRB) has a Cash Flow Reinvestment Rate of 0.01x as of September 2025, reinvesting $16.00K (capex $8.00K plus investments $-8.00K) from operating cash flow of $2.21 Million. Check MCRB cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Seres Therapeutics Inc Cash Flow Reinvestment Rate (2016–2025)
Historical reinvestment intensity for Seres Therapeutics Inc across 3 annual periods. Explore MCRB strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for Seres Therapeutics Inc (2016–2025)
Year-by-year capital reinvestment analysis for Seres Therapeutics Inc. For live market cap and broader valuation context, see MCRB market cap overview.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.23x | $252.00K | $1.12 Million | $252.00K | ▼ -98.2% |
| 2021 | 12.44x | $83.22 Million | $6.69 Million | $9.57 Million | ▲ +733.2% |
| 2016 | 1.49x | $65.59 Million | $43.92 Million | $21.49 Million | — |